Trials / Conditions / Supranuclear Palsy, Progressive

Supranuclear Palsy, Progressive

9 registered clinical trials studyying Supranuclear Palsy, Progressive — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Neurodegenerative Diseases Progression Markers (MARKERS-NDD) NCT06596746	Casa di Cura San Raffaele Cassino	—
Recruiting	Transcranial Magnetic Stimulation in Progressive Supranuclear Palsy NCT04468932	Oregon Health and Science University	N/A
Terminated	Study of BIIB092 in Participants With Progressive Supranuclear Palsy NCT03068468	Biogen	Phase 2
Completed	More Than a Movement Disorder: Applying Palliative Care to Parkinson's Disease NCT03076671	University of Colorado, Denver	N/A
Completed	Application of Machine Learning Method in Validation of Screening Cognitive Test for Parkinsonisms NCT04858893	Ospedale Generale Di Zona Moriggia-Pelascini	—
Terminated	Extension Study of BIIB092 in Participants With Progressive Supranuclear Palsy (PSP) Who Participated in CN002 NCT02658916	Biogen	Phase 1
Completed	Defining Phenotypes of Movement Disorders :Parkinson's Plus Disorders (PD), Essential Tremor (ET), Cortical Ba NCT02132052	University of Colorado, Denver	—
Completed	Transcranial Duplex Scanning and Single Photon Emission Computer Tomography (SPECT) in Parkinsonian Syndromes NCT00368199	Maastricht University Medical Center	—
Unknown	Study of the Distractibility Syndrome in Patients With Progressive Supranuclear Palsy NCT00139373	Groupe Hospitalier Pitie-Salpetriere	Phase 2